drugset / Press release
Chinese Phase III Clinical Trials of rhNRG-1 are Recruiting Patients
2011-01-11 · Zensun Sci. & Tech. Co., Ltd. · original zensun.com ↗
Zensun's first-in-class innovative drug rhNRG-1 are now underging Chinese phase III clinical trials. So far, there are 70 hospitals participating in this study. At the same, US phase II clinical trial of rhNRG-1 is recruiting patients.
The release as fetched from its publisher. zensun.com ↗